Calepusan, Samuel S.

HRN: 29-23-01  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2026
CO-AMOXICLAV 625MG (TAB)
06/28/2026
04/07/2026
PO
625
Q8
TBI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: Compliant To Guidelines